Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Miami, FL

101 studies for Lung Cancer are recruiting at 175 sites within 50 miles of Miami, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Miami.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Miami

Showing the 50 nearest of 101 studies.
  1. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute (Miami, FL); UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  2. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL); University of Miami Miller School of Medicine-Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  3. Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

    NCT06463665

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Bioresearch Partner (Miami, FL); University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  4. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baptist Health Miami Cancer Institute (Miami, FL); Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  6. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Veterans Affairs Healthcare System (Miami, FL); GenesisCare USA (Aventura, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

    NCT05317858

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health (Miami, FL); Broward Health (Fort Lauderdale, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health, Inc. (Miami, FL); Millennium Oncology Research Clinic (Hollywood, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health, Inc. ( Site 0214) (Miami, FL); The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156) (Fort Lauderdale, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

    NCT06627647

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Miami, FL); Research Site (Fort Lauderdale, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health, Inc. (Miami, FL); Boca Raton Regional Hospital (Boca Raton, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

    NCT02984761

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Miami VA Healthcare System, Miami, FL (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #47 (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

    NCT05267626

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center - Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

    NCT05366881

    • Observational
    • Ages 40 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Miami Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

    NCT05443126

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Empathic Communication Skills (ECS) Training

    NCT05456841

    • Interventional
    • Ages 18 to 100 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: BAPTIST ALLIANCE - MCI (Data Collection Only) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

    NCT05657873

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: BAPTIST ALLIANCE - MCI (Data Collection Only) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

    NCT05882058

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    NCT06203210

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    NCT06239194

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center - University of Miami Health System (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

    NCT06293898

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

    NCT06426628

    • Observational
    • Ages 29 to 85 years
    • Sex: All

    Nearest site: Bruce W. Carter Miami VA Medical Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study of VET3-TGI in Patients With Solid Tumors

    NCT06444815

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

    NCT06561685

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

    NCT06618287

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Hospital and Clinics, Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

    NCT06626243

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baptist Health South Florida (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    NCT06657222

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

    NCT06667908

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

    NCT06741085

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: BAPTIST ALLIANCE - MCI (Data Collection Only) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

    NCT06765109

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

    NCT06780137

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

    NCT06801834

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Boca Raton Regional (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

    NCT06902272

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    NCT07020117

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Biogenix Molecular, LLC (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

    NCT07057791

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

    NCT07288177

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Hospital (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    NCT07488676

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Miami Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

    NCT07625644

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Total Health and Research Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Medical Center (Miami Beach, FL); Mount Sinai Comprehensive Cancer Center at Aventura (Aventura, FL)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    6 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.